Close Menu

Nelson Chan
Twist Bioscience has appointed Nelson Chan to its board of directors. Chan has been an advisor to Twist for the last 18 months for the firm's DNA data storage business. Chan is also chairman of the board at Synaptics and Adesto, as well as executive chairman of HZO. He previously served as CEO of Magellan and has also held various senior management roles at SanDisk Corporation. Chan will replace Paul Conley, managing director of Paladin Capital Group, who has served on Twist's board since 2013.


David Fenstermacher

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.